CN1022186C - 二氮杂双环化合物的制备方法 - Google Patents

二氮杂双环化合物的制备方法 Download PDF

Info

Publication number
CN1022186C
CN1022186C CN90100291A CN90100291A CN1022186C CN 1022186 C CN1022186 C CN 1022186C CN 90100291 A CN90100291 A CN 90100291A CN 90100291 A CN90100291 A CN 90100291A CN 1022186 C CN1022186 C CN 1022186C
Authority
CN
China
Prior art keywords
formula
nmr
hrms
preparation
tlc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN90100291A
Other languages
English (en)
Chinese (zh)
Other versions
CN1044464A (zh
Inventor
基沙·安姆拉特拉尔·迪沙伊
吉恩·迈克尔·布赖特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp SRL filed Critical Pfizer Corp SRL
Publication of CN1044464A publication Critical patent/CN1044464A/zh
Application granted granted Critical
Publication of CN1022186C publication Critical patent/CN1022186C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
CN90100291A 1989-01-23 1990-01-22 二氮杂双环化合物的制备方法 Expired - Fee Related CN1022186C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US1989/000275 WO1990008148A1 (en) 1989-01-23 1989-01-23 Bis-aza-bicyclic anxiolytic agents
USPCT/US89/00275 1989-01-23
USPCT/US89/03811 1989-09-01
PCT/US1989/003811 WO1990008144A1 (en) 1989-01-23 1989-09-01 Bis-aza-bicyclic anxiolytic agents

Publications (2)

Publication Number Publication Date
CN1044464A CN1044464A (zh) 1990-08-08
CN1022186C true CN1022186C (zh) 1993-09-22

Family

ID=22214801

Family Applications (1)

Application Number Title Priority Date Filing Date
CN90100291A Expired - Fee Related CN1022186C (zh) 1989-01-23 1990-01-22 二氮杂双环化合物的制备方法

Country Status (38)

Country Link
US (1) US5122525A (enExample)
EP (1) EP0380217B1 (enExample)
JP (1) JPH0643427B2 (enExample)
KR (1) KR910009289B1 (enExample)
CN (1) CN1022186C (enExample)
AP (1) AP128A (enExample)
AR (1) AR246969A1 (enExample)
AT (1) ATE82574T1 (enExample)
AU (1) AU614214B2 (enExample)
BA (1) BA98302A (enExample)
BG (1) BG51046A3 (enExample)
CA (1) CA2008108C (enExample)
CZ (1) CZ277698B6 (enExample)
DD (1) DD291560A5 (enExample)
DE (1) DE69000467T2 (enExample)
DK (1) DK0380217T3 (enExample)
EG (1) EG19306A (enExample)
ES (1) ES2053094T3 (enExample)
FI (1) FI95381C (enExample)
GR (1) GR3006925T3 (enExample)
HU (1) HU215154B (enExample)
IE (1) IE62670B1 (enExample)
IL (1) IL93073A (enExample)
IS (1) IS1667B (enExample)
MA (1) MA21735A1 (enExample)
MX (1) MX19222A (enExample)
MY (1) MY104861A (enExample)
NO (1) NO175978C (enExample)
NZ (1) NZ232168A (enExample)
OA (1) OA10041A (enExample)
PL (1) PL163836B1 (enExample)
PT (1) PT92919B (enExample)
RO (1) RO110142B1 (enExample)
RU (1) RU2015977C1 (enExample)
SK (1) SK279339B6 (enExample)
WO (2) WO1990008148A1 (enExample)
YU (1) YU47554B (enExample)
ZA (1) ZA90430B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
WO1992000075A1 (en) * 1990-06-29 1992-01-09 Pfizer Inc. Pyridopyrazine derivatives for treating substance abuse and addiction
EP0569387B1 (en) * 1991-01-31 1995-04-05 Pfizer Inc. Resolution of trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido 1,2-a]pyrazine
EP0573464B1 (en) * 1991-02-27 1997-03-19 Pfizer Inc. Process for preparing trans-piperidine-2,5-dicarboxylates
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
US5311195A (en) * 1991-08-30 1994-05-10 Etak, Inc. Combined relative and absolute positioning method and apparatus
JPH08827B2 (ja) * 1991-09-25 1996-01-10 フアイザー・インコーポレイテツド 精神弛緩剤の２−置換パーヒドロ−１Ｈ−ピリド［１，２−ａピラジン
DK0646116T3 (da) * 1992-06-16 1999-12-27 Pfizer Fremgangsmåde og mellemprodukter til fremstilling af bis-aza-bicycliske anxiolytiske midler
AU5291793A (en) * 1992-09-24 1994-04-12 National Institutes Of Health Aralkyl diazabicycloalkane derivatives for cns disorders
IL104506A (en) * 1993-01-25 1997-11-20 Israel State Fast changing heating- cooling device and method, particularly for cryogenic and/or surgical use
US5637713A (en) * 1993-08-20 1997-06-10 Pfizer Inc. Process for preparing trans-piperidine-2,5-dicarboxylates
US5455350A (en) * 1993-10-13 1995-10-03 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
IL107460A (en) * 1993-11-01 1999-06-20 Israel State Controlled cryogenic contact system
UA50720C2 (uk) * 1994-09-30 2002-11-15 Пфайзер, Інк. 2,7-заміщені похідні октагідро-1н-піридо[1,2a]піразину, фармацевтична композиція та спосіб лікування
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
KR100286786B1 (ko) * 1995-12-21 2001-04-16 디. 제이. 우드, 스피겔 알렌 제이 2,7-치환된옥타하이드로-피롤로[1,2-에이]피라진유도체
PL330962A1 (en) * 1996-07-01 1999-06-21 Pfizer Method of obtaining (7s, trans)-2- (2-pyrimidinyl) -7- (hydroxymethyl) octahydro -2h-pyrido [1,2-a] pyrazine _
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
US6251893B1 (en) * 1998-06-15 2001-06-26 Nps Allelix Corp. Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
US6670476B2 (en) 2000-11-29 2003-12-30 Pfizer Inc. Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
PL378749A1 (pl) * 2003-03-12 2006-05-15 Pfizer Products Inc. Azabicykliczne pochodne pirydyloksymetylowe i benzoizoksazolowe
EP1633756B1 (en) 2003-04-09 2008-12-24 Biogen Idec MA Inc. A2a adenosine receptor antagonists
JP4864719B2 (ja) * 2003-11-26 2012-02-01 ファイザー・プロダクツ・インク Ｇｓｋ−３インヒビターとしてのアミノピラゾール誘導体
MXPA06013762A (es) * 2004-05-27 2007-02-08 Warner Lambert Co Combinacion de atomoxetina y un agonista del receptor 5t1a para el tratamiento de trastorno de hiperactividad con deficit de atencion y otros trastornos.
US7658206B2 (en) 2006-12-05 2010-02-09 Kohler Co. Plumbing valve with stick control handle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4339579A (en) * 1980-12-29 1982-07-13 American Home Products Corporation 2,6-Bis-(pyrrolopyrazinyl)pyrazines
US4400511A (en) * 1982-05-07 1983-08-23 American Home Products Corporation 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids
US4414389A (en) * 1982-05-25 1983-11-08 American Home Products Corporation 4-Substituted-piperidino carboxamides
US4517187A (en) * 1982-10-18 1985-05-14 Pennwalt Corporation 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3409440A1 (de) * 1984-03-15 1985-09-26 Bayer Ag, 5090 Leverkusen Imidazo(1,5-a)pyridyl-methan- und imidazo(1,5-b)pyridazinylmethan-derivate, ihre herstellung und sie enthaltende aufzeichnungsmaterialien
IT1204803B (it) * 1986-02-17 1989-03-10 Acraf Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono,procedimento per prepararlo e intermedio utile in detto procedimento
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
JP2668259B2 (ja) * 1988-02-18 1997-10-27 塩野義製薬株式会社 複素環化合物および抗潰瘍剤
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents

Also Published As

Publication number Publication date
PT92919A (pt) 1990-07-31
KR900011774A (ko) 1990-08-02
EG19306A (en) 1995-01-31
WO1990008144A1 (en) 1990-07-26
AU614214B2 (en) 1991-08-22
MA21735A1 (fr) 1990-10-01
RO110142B1 (ro) 1995-10-30
FI913510A0 (fi) 1991-07-22
MY104861A (en) 1994-06-30
CZ277698B6 (en) 1993-03-17
KR910009289B1 (ko) 1991-11-09
IE900225L (en) 1990-07-23
IS1667B (is) 1997-11-14
DE69000467D1 (de) 1992-12-24
FI95381B (fi) 1995-10-13
CA2008108C (en) 1995-08-08
EP0380217A1 (en) 1990-08-01
YU47554B (sh) 1995-10-03
US5122525A (en) 1992-06-16
MX19222A (es) 1993-12-01
HUT63163A (en) 1993-07-28
RU2015977C1 (ru) 1994-07-15
NO912863L (no) 1991-07-22
DK0380217T3 (da) 1992-12-14
DE69000467T2 (de) 1993-04-01
BG51046A3 (bg) 1993-01-15
PL163836B1 (pl) 1994-05-31
EP0380217B1 (en) 1992-11-19
BA98302A (bs) 2001-09-14
NO175978B (no) 1994-10-03
AP9000158A0 (en) 1990-01-31
HU215154B (hu) 2000-09-28
NO912863D0 (no) 1991-07-22
AP128A (en) 1991-03-20
NZ232168A (en) 1991-08-27
DD291560A5 (de) 1991-07-04
YU11190A (sh) 1993-05-28
AR246969A1 (es) 1994-10-31
CS29990A3 (en) 1992-11-18
CN1044464A (zh) 1990-08-08
SK279339B6 (sk) 1998-10-07
CA2008108A1 (en) 1990-07-23
PT92919B (pt) 1995-12-29
IE62670B1 (en) 1995-03-08
JPH0643427B2 (ja) 1994-06-08
IS3529A7 (is) 1990-07-24
NO175978C (no) 1995-01-11
FI95381C (fi) 1996-01-25
JPH02233681A (ja) 1990-09-17
ATE82574T1 (de) 1992-12-15
IL93073A (en) 1994-05-30
AU4867990A (en) 1990-07-26
OA10041A (en) 1996-10-14
ES2053094T3 (es) 1994-07-16
ZA90430B (en) 1991-08-28
GR3006925T3 (enExample) 1993-06-30
WO1990008148A1 (en) 1990-07-26

Similar Documents

Publication Publication Date Title
CN1022186C (zh) 二氮杂双环化合物的制备方法
CN1174980C (zh) 抑制胃酸分泌的咪唑并吡啶衍生物
CN1109052A (zh) 嘧啶和吡啶衍生物，它们的生产和应用
CN1044811A (zh) 杂环化合物
CN1168720C (zh) 芳基链烷酰基哒嗪化合物
CN1075957A (zh) 萘衍生物、其制备方法及其合成中间体
CN1067889A (zh) 取代的n-(1-烷基-3-羟基-4-哌啶基)苯甲酰胺的制备方法
CN1091742A (zh) 水溶性喜树碱衍生物
CN1206407A (zh) 取代的乙烯基吡啶衍生物和含有它们的药物
CN1072929A (zh) 对二氮萘衍生物、其制法及其医药用途
HK1043593A1 (zh) 3-取代的吡啶並[4'，3'：4，5]噻吩並[2，3-d]嘧啶衍生物，它們的製備和應用
CN1250551C (zh) 控制炎性细胞因子的螺环－6,7－二氢－5h－吡唑[1,2－a]吡唑－1－酮
CN1067892A (zh) 新的吡咯并[2，3-b]吡啶衍生物的制备方法
CN1503797A (zh) 吡啶并嘧啶或二氮杂萘衍生物
CN1552714A (zh) 2-取代苯基-5，7-二烃基-3，7-二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其药物用途
CN1205704A (zh) 2,7－取代的八氢－吡咯并[1,2－a]吡嗪衍生物
CN1179962C (zh) 氮杂吲哚嗪酮衍生物和以其为有效成分的脑功能改善剂
CN85108132A (zh) 化合物制备方法
CN1069271A (zh) 制备[1]苯并吡喃并[4，3-c]吡唑类化合物的方法
CN1823054A (zh) 咪唑衍生物ⅲ
CN1262685A (zh) 萘啶衍生物
CN1128147C (zh) 作为5－ht1a受体配体的3－氧代－2(h)－1,2,4－三嗪衍生物
CN1074440A (zh) 胃酸分泌抑制及胃细胞保护性药物组合物，新的法莫替丁(famotidinc)盐及其制备方法
CN1062526A (zh) 烷氨基烷基胺和醚化合物及其制造方法和中间产物以及含这些化合物的药剂
CN1349527A (zh) 取代的苯并内酰胺化合物

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee